UCL-1530

N/A

Report date: 2025/02/05 13:46:28
NME

Base Information

Drug NameUCL-1530
Drug Alias NameUCL-1530
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPotassium channel blockers
TargetsPotassium channelVoltage-gated potassium channel subunit Kv1.3
Therapy Area/IndicationsHypertensionArrhythmias, Cardiac
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUniversity College London
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity College London
Active IndicationsN/A
Inactive IndicationsHypertensionArrhythmias, Cardiac

Other Information

ATC CodeN/A
Related LinksN/A